Skip to main content

Table 2 Mortality at 30 days

From: Can minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study

  All Patients n (%) Groups
     A, n = 84 (%)   B, n = 114 (%)   
  Dead (GOS = 1) Survival GOS > 1) P Dead (GOS = 1) Survival GOS > 1) Total Dead (GOS = 1) Survival (GOS > 1) Total P
Total 64 (32.3) 134 (67.7)   23 (27.4) 61 (72.6) 84 41 (36.0) 73 (64.0) 114 0.203
Age           0.203
60 42 (32.3) 88 (67.7) 0.995 9 (20.0) 36 (80.0) 45 33 (38.8) 52 (61.2) 85 0.030
 > 60 22 (32.4) 46 (67.6) 14 (35.9) 25 (64.1) 39 8 (27.6) 21 (72.4) 29 0.472
Gender           0.203
 Female 14 (25.9) 40 (74.1) 0.240 4 (18.2) 18 (81.8) 22 10 (31.3) 22 (68.8) 32 0.286
 Male 50 (34.7) 94 (65.3) 19 (30.6) 43 (69.4) 62 31 (37.8) 51 (62.2) 82 0.373
Diabetes           0.203
 No 34 (26.8) 93 (73.2) 0.026 12 (20.0) 48 (80.0) 60 22 (32.8) 45 (67.2) 67 0.104
 Yes 30 (42.3) 41 (57.7) 11 (45.8) 13 (54.2) 24 19 (40.4) 28 (59.6) 47 0.665
GCS    <0.001        0221
 15-13 grade 1 2 (6.7) 28 (93.3)   0 (0.0) 17 (100.0) 17 2 (15.4) 11 (84.6) 13 0.179
 12-7 grade 2 21 (23.9) 67 (76.1) 0.059a 7 (18.9) 30 (81.1) 37 14 (27.5) 37 (72.5) 51 0.357
 6-3 grade 3 41 (51.3) 39 (48.8) <0.001b 16 (53.3) 14 (46.7) 30 25 (50.0) 25 (50.0) 50 0.477
NIHSS    0.001        0.221
 <15 grade 1 5 (15.6) 27 (84.4)   0 (0.0) 17 (100) 17 5 (33.3) 10 (66.7) 15 0.015
 15-20 grade 2 9 (18.0) 41 (82.0) 1.000.a 3 (13.6) 19 (86.4) 22 6 (21.4) 22 (78.6) 28 0.713
 >20 grade 3 50 (43.1) 66 (56.9) 0.002b 20 (44.4) 25 (55.6) 45 30 (42.3) 41 (55.7) 71 0.817
HV, mL           0.203
60 29 (22.1) 102 (77.9) <0.001 8 (13.1) 53 (86.9) 61 21 (30.0) 49 (70.0) 70 0.021
 > 60 35 (52.5) 32 (47.8) 15 (65.2) 8 (34.8) 23 20 (45.5) 24 (54.5) 44 0.127
IVH    <0.001        0.221
 0 12 (18.8) 52 (81.3)   3 (10.0) 27 (90.0) 30 9 (26.5) 25 (73.5) 34 0.117
 1-4 grade 1 10 (16.1) 52 (83.9) 0.816c 3 (11.1) 24 (88.9) 27 7 (20.0) 28 (80.0) 35 0.491
 5-8 grade 2 19 (52.8) 17 (47.2) <0.001a 6 (40.0) 9 (60.0) 15 13 (61.9) 8 (38.1) 21 0.201
 9-12 grade 3 23 (63.9) 13 (36.1) 0.471b 11 (91.7) 1 (8.3) 12 12 (50.0) 12 (50.0) 24 0.025
Complications, n (%)          
RB           0.221
  No 57 (30.2) 132 (69.8) 0.006 22 (26.5) 61 (73.5) 83 35 (33.0) 71 (67.0) 106 0.334
  Yes 7 (77.8) 2 (22.2) 1 (100) 0 (0.0) 1 6 (75.0) 2 (25.0) 8 1.000
RF           0.221
  NO 50 (28.2) 127 (71.8) 0.001 19 (24.1) 60 (75.9) 79 31 (31.6) 67 (68.4) 98 0.267
  Yes 14 (66.7) 7 (33.3) 4 (80.0) 1 (20.0) 5 10 (62.5) 6 (37.5) 16 0.624
PI           0.203
  No 31 (26.7) 85 (73.3) 0.046 12 (24.0) 38 (76.0) 50 19 (28.8) 47 (71.2) 66 0.566
  Yes 33 (40.2) 49 (59.8) 11 (32.4) 23 (67.6) 34 22 (45.8) 26 (54.2) 48 0.223
UGB           0.221
  No 56 (30.6) 127 (69.4) 0.087 19 (24.7) 58 (75.3) 77 37 (34.9) 69 (65.1) 106 0.139
  Yes 8 (53.3) 7 (46.7) 4 (57.1) 3 (42.9) 7 4 (50.0) 4 (50.0) 8 1.000
  1. P values were calculated using the Wilcoxon or Kruskal-Wallis rank sum tests. Groups: A, minimal invasive puncture and drainage; B, decompressive craniectomy; GOS: Glasgow Outcome Scale; BP: blood pressure; SPB systolic blood pressure. DBP: diastolic blood pressure. GCS: Glasgow Coma Scale; NIHSS: National Institutes of Health Stroke Scale; HV: hematoma volume; IVH: intraventricular hemorrhage; RB: rebleed; PI: pulmonary infection; RF: renal failure; UGB: upper gastrointestinal bleeding; agrade 1 vs. grade 2; bgrade 2 vs. grade 3; cIVH 0 vs. IVH grade 1.